Gladstone NOW: The Campaign Join Us on the Journey ✕
121 - 135 of 136 Results Clear All
Gladstone’s new president discusses his new role
Office of the President History Institutional News Profile Srivastava Lab
Williams led the institution through a critical period in its history
History Institutional News
Todd McDevitt becomes program director and co-chair of the executive committee
Institutional News Cardiovascular Disease McDevitt Lab
Lorenz Studer is honored for his groundbreaking research in stem cell–based therapies for Parkinson’s disease.
Awards Institutional News Ogawa Stem Cell Prize Stem Cells/iPSCs
Simon takes on a central role in shaping Gladstone’s future
History Institutional News
A founding trustee of Gladstone will step down after committing more than 45 years to to giving scientists the freedom to advance science.
History Institutional News Profile
Bay Area philanthropist leaves a legacy as a long-time friend and supporter of the Gladstone Institutes.
Institutional News
A new biopharmaceutical company, Tenaya Therapeutics Inc., will build on discoveries in cardiovascular disease research made at the Gladstone Institutes, concentrating on regenerative medicine and drug discovery for heart failure.
Institutional News News Release Heart Failure
Douglas Melton was honored for his research that led to a novel way to reprogram human stem cells into insulin-producing beta cells.
Awards Institutional News Ogawa Stem Cell Prize
Douglas Melton was honored for his research that led to a novel way to reprogram human stem cells into insulin-producing beta cells.
Awards Institutional News Ogawa Stem Cell Prize
It is a historic time at the Gladstone Institutes; William S. “Bill” Price, III, has joined the Gladstone Trustees. Price replaces Albert A. Dorman, who served Gladstone for almost 30 years.
Although new as a Trustee, Price has been involved with Gladstone for many years, beginning in 2004 as a member of the Gladstone Advisory Council.
Bob Obana will oversee all administrative services as the newest member of Gladstone's leadership team.
Office of the Chief Operating Officer Institutional News
Trustee Al Dorman has been instrumental in guiding Gladstone into a new building and a new era of scientific research.
Institutional News
Diversity Interns celebrated their research accomplishments after completing summer internships in labs at Gladstone.
Institutional News
With the opening of the Thermo Fisher Scientific Proteomics Facility for Disease Target Discovery, the Gladstone Institutes has taken a major step forward in accelerating protein research.
Institutional News Mass Spectrometry Facility
